Healthcare provider profile · identity verified

Sean E Anderson, M.D.

Family Practice · SAINT LOUIS PARK, MN · NPI 1548247190

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1050	311
Amlodipine Besylate	Amlodipine Besylate	585	178
Losartan Potassium	Losartan Potassium	529	154
Lisinopril	Lisinopril	513	156
Omeprazole	Omeprazole	445	131
Simvastatin	Simvastatin	305	80
Levothyroxine Sodium	Levothyroxine Sodium	295	82
Metoprolol Succinate	Metoprolol Succinate	277	79
Hydrochlorothiazide	Hydrochlorothiazide	262	78
Metformin Hcl Er	Metformin Hcl	252	68
Tamsulosin Hcl	Tamsulosin Hcl	236	72
Gabapentin	Gabapentin	224	66
Furosemide	Furosemide	188	55
Atenolol	Atenolol	165	49
Fluticasone Propionate	Fluticasone Propionate	151	55
Zolpidem Tartrate	Zolpidem Tartrate	146	31
Metformin Hcl	Metformin Hcl	145	43
Allopurinol	Allopurinol	144	40
Triamcinolone Acetonide	Triamcinolone Acetonide	129	64
Trazodone Hcl	Trazodone Hcl	128	39
Rosuvastatin Calcium	Rosuvastatin Calcium	122	39
Glipizide Er	Glipizide	121	37
Albuterol Sulfate Hfa	Albuterol Sulfate	119	61
Warfarin Sodium	Warfarin Sodium	115	25
Pantoprazole Sodium	Pantoprazole Sodium	111	31
Sertraline Hcl	Sertraline Hcl	104	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	95	25
Bupropion Xl	Bupropion Hcl	93	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	85	28
Xarelto	Rivaroxaban	85	15
Alprazolam	Alprazolam	83	14
Eliquis	Apixaban	83	26
Ozempic	Semaglutide	80	19
Carvedilol	Carvedilol	69	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	20
Clopidogrel	Clopidogrel Bisulfate	65	20
Tramadol Hcl	Tramadol Hcl	60	14
Fluoxetine Hcl	Fluoxetine Hcl	59	13
Finasteride	Finasteride	57	21
Lorazepam	Lorazepam	53	20
Paroxetine Hcl	Paroxetine Hcl	50	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	23
Mirtazapine	Mirtazapine	48	15
Potassium Chloride	Potassium Chloride	48	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	20
Escitalopram Oxalate	Escitalopram Oxalate	45	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	44	12
Jardiance	Empagliflozin	43	11
Oxycodone Hcl	Oxycodone Hcl	43	16
Pravastatin Sodium	Pravastatin Sodium	43	14
Doxycycline Hyclate	Doxycycline Hyclate	42	12
Trulicity	Dulaglutide	41	suppressed
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Prednisone	Prednisone	40	35
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	39	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	38	22
Hydromorphone Hcl	Hydromorphone Hcl	38	suppressed
Ketoconazole	Ketoconazole	38	19
Temazepam	Temazepam	37	suppressed
Azithromycin	Azithromycin	36	26
Valacyclovir	Valacyclovir Hcl	36	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Pregabalin	Pregabalin	34	suppressed
Ventolin Hfa	Albuterol Sulfate	34	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Spironolactone	Spironolactone	33	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	33	16
Alendronate Sodium	Alendronate Sodium	32	suppressed
Diazepam	Diazepam	32	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Clonazepam	Clonazepam	29	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	suppressed
Humalog Kwikpen U-100	Insulin Lispro	28	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Famotidine	Famotidine	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Primidone	Primidone	25	suppressed
Baclofen	Baclofen	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Gemfibrozil	Gemfibrozil	23	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Glipizide	Glipizide	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Nitroglycerin	Nitroglycerin	20	11
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Amoxicillin	Amoxicillin	19	12
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Dutasteride	Dutasteride	18	suppressed
Eszopiclone	Eszopiclone	18	suppressed
Potassium Citrate Er	Potassium Citrate	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Synthroid	Levothyroxine Sodium	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	13
Azelastine Hcl	Azelastine Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Estradiol	Estradiol	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	14
Pen Needles	Pen Needle, Diabetic	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Naproxen	Naproxen	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Rivastigmine	Rivastigmine Tartrate	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Testosterone	Testosterone	14	suppressed
Desonide	Desonide	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Dicloxacillin Sodium	Dicloxacillin Sodium	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error